T-cell lymphoma

May 20, 2016May 20, 2016

Tanoto Foundation Gives Lymphoma Research $2.5M Boost

News

The SingHealth Duke-NUS Academic Medical Center partnership has announced that a $2.5 million Tanoto Foundation Professorship in Medical Oncology has been conferred to Associate Prof. Lim Soon Thye, head and ... Read more

February 16, 2016March 8, 2016

Negative-Data Clinical Trials in Lymphoma

To stay updated with the latest lymphoma clinical trials news, click here: http://bit.ly/1QoY2Uw Learn more about what happens after a lymphoma clinical trial ends here: http://bit.ly/1Rp5aB2

February 5, 2016May 13, 2016

Potential Lymphoma Drug, Aplidin, May Become Available in 12 Asian Countries

News

PharmaMar has signed an agreement with Singapore-based Specialised Therapeutics Asia to market Aplidin (plitidepsin), a marine-based anti-tumor compound under development for the treatment of hematological tumors, including lymphoma, in 12 Southeast Asian ... Read more

January 4, 2016March 2, 2016

T-Cell Lymphoma Survivor: Mr. T’s Story

In this 2009 video, “Mr. T tells the story of his battle with T-Cell Lymphoma and how he chose to fight it.” He is now cancer free and a lymphoma ... Read more

November 25, 2015March 8, 2016

Isabel and T-Cell Non-Hodgkin’s Lymphoma: Watch Her Story

https://www.youtube.com/watch?v=uPFOvuxY__A https://www.youtube.com/watch?v=5DJMw2QxDk0 Learn more about Non-Hodgkin’s Lymphoma: http://bit.ly/1Gvngyx

August 24, 2015August 24, 2015

UCN-01 (7-Hydroxystaurosporine) Yields Complete Response in Some T-Cell Lymphoma Patients

News

A completed Phase 2 clinical trial in relapsed or refractory systemic Anaplastic Large Cell Lymphoma (ALCL) demonstrated that the experimental drug UCN-01 (7-hydroxystaurosporine) produced a complete clinical response in 18% ... Read more